This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Houston, K. D. Articles by Walker, C. L. Search for Related Content PubMed PubMed Citation Articles by Houston, K. D. Articles by Walker, C. L. Social Bookmarking                         What's this?

Uterine Leiomyomas: Mechanisms of Tumorigenesis

Department of Carcinogenesis, Science Park-Research Division, University of Texas M. D. Anderson Cancer Center, Smithville, Texas 78957

Deborah S. Hunter

Department of Carcinogenesis, Science Park-Research Division, University of Texas M. D. Anderson Cancer Center, Smithville, Texas 78957

Leslie C. Hodges

Department of Carcinogenesis, Science Park-Research Division, University of Texas M. D. Anderson Cancer Center, Smithville, Texas 78957

Cheryl L. Walker

Department of Carcinogenesis, Science Park-Research Division, University of Texas M. D. Anderson Cancer Center, Smithville, Texas 78957, cwalker{at}odin.mdacc.tmc.edu

Uterine leiomyomas, also called fi broids, are the most common reproductive tract neoplasm and the leading indication for hysterectomy in premenopausal women. The discovery and development of medicinal therapies for uterine leiomyoma have been hampered by a lack of understanding regarding the etiology and molecular mechanisms underlying the development of these lesions. Although the estrogen responsiveness of uterine leiomyoma is well established, the impact of environmental estrogens and their contribution to the development of these tumors is currently unknown. The Eker rat model of uterine leiomyoma has proven useful for addressing these issues and understanding the pathophysiology of this disease. The Eker rat is the only animal model that develops spontaneous uterine leiomyomas, and these tumors share many characteristics with those found in humans. The availability of tumor-derived cell lines from these rats has made this a valuable in vitro/in vivo model system for experimental studies to investigate molecular mechanisms of disease and to design interventional and preventative strategies for this clinically relevant tumor.

Key Words: Estrogen • steroid • hormone • Tsc-2 • rat • myometrium • xenoestrogen • uterus

References

• Adamson GD (1992). Treatment of uterine fibroids: Current fi ndings with gonadotropin-releasing hormone agonists. Am J Obstet Gynecol 166: 746—751.[Web of Science][Medline] [Order article via Infotrieve]
• Andersen J., Barbieri RL (1995). Abnormal gene expression in uterine leiomyomas. J Soc Gynecol Invest 2: 663—672.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Andreyko JL, Marshall LA, Dumesic DA, Jaffe RB (1987). Therapeutic uses of gonadotropin-releasing hormone analogs. Obstet Gynecol Surv 42: 1—21.[Medline] [Order article via Infotrieve]
• Burroughs KD, Howe SR, Okubo Y., Fuchs-Young R., LeRoith D., Walker CL (in press). Disregulation of insulin-like growth factor-I signalling in uterine leiomyoma. Mol Carcinog.
• Burroughs K., Fuchs-Young R., Davis B., Walker C. (2000). Altered hormonal responsiveness of proliferation and apoptosis during myometrial maturation and the development of uterine leiomyomas. Biol Reprod 63: 1322—1330.[Abstract/Free Full Text]
• Burroughs KD, Kiguchi K., Howe SR, Fuchsyoung R., Trono D., Barrett JC, Walker C. (1997). Regulation of apoptosis in uterine leiomyomata. Endocrinology 138: 3056—3064.[Abstract/Free Full Text]
• Buttram VCJr, Reiter RC (1981). Uterine leiomyomata: Etiology, symptomatology, and management. Fertil Steril 36: 433—445.[Web of Science][Medline] [Order article via Infotrieve]
• Chiaffarino F., Parazzini F., La Vecchia C., Chatenoud L., Di Cintio E., Marsico S. (1999). Diet and uterine myomas. Obstet Gynecol 94: 395—398.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Chiaffarino F., Parazzini F., La Vecchia C., Marsico S., Surace M., Ricci E. (1999). Use of oral contraceptives and uterine fibroids: Results from a case-control study. Br J Obstet Gynaecol 106: 857 — 860.[Web of Science][Medline] [Order article via Infotrieve]
• Chiaffarino F., Parazzini F., La Vecchia C., Ricci E., Crosignani PG (1998). Oral contraceptive use and benign gynecologic conditions. A review. Contraception 57: 11—18.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Cramer S., Patel A. (1990). The frequency of uterine leiomyomas. Am J Clin Pathol 94: 435—438.[Web of Science][Medline] [Order article via Infotrieve]
• Everitt JI, Wolf DC, Howe SR, Goldsworthy TL, Walker C. (1995). Rodent model of reproductive tract leiomyomata. Clinical and pathological features. Am J Pathol 146: 1556—1567.[Abstract]
• Fuchs-Young R., Howe S., Hale L., Miles R., Walker C. (1996). Inhibition of estrogen-stimulated growth of uterine leiomyomas by selective estrogen receptor modulators. Mol Carcinog 17: 151—159.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Ghahary A., Chakrabarti S., Murphy LJ (1990). Localization of the sites of synthesis and action of insulin-like growth factor-I in the rat uterus. Mol Endocrinol 4: 191—195.[Abstract/Free Full Text]
• Grese TA, Dodge JA (1998). Selective estrogen receptor modulators (SERMs). Curr Pharm Design 4: 71—92.[Web of Science][Medline] [Order article via Infotrieve]
• Hodges LC, Bergerson JS, Hunter DS, Walker CL (2000). Estrogenic effects of organochlorine pesticides on uterine leiomyoma cells in vitro. Toxicol Sci 54: 355—364.[Abstract/Free Full Text]
• Howe SR, Everitt JL, Gottardis MM, Walker C. (1997). Rodent model of reproductive tract leiomyomata: Characterization and use in preclinical therapeutic studies. Prog Clin Biol Res 396: 205— 215.[Web of Science][Medline] [Order article via Infotrieve]
• Howe SR, Gottardis MM, Everitt JI, Goldsworthy TL, Wolf DC, Walker C. (1995). Rodent model of reproductive tract leiomyomata. Establishment and characterization of tumor-derived cell lines. Am J Pathol 146: 1568—1579.[Abstract]
• Howe SR, Gottardis MM, Everitt JI, Walker C. (1995). Estrogen stimulation and tamoxifen inhibition of leiomyoma cell growth in vitro and in vivo. Endocrinology 136: 4996—5003.[Abstract]
• Hoyer AP, Grandjean P., Jorgensen T., Brock JW, Hartvig HB (1998). Organochlorine exposure and risk of breast cancer. Lancet 352: 1816—1820.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Hunter DS, Hodges LC, Vonier PM, Fuchs-Young R., Gottardis MM, Walker CL (1999). Estrogen receptor activation via activation function 2 predicts agonism of xenoestrogens in normal and neoplastic cells of the uterine myometrium. Cancer Res 59: 3090 — 3099.[Abstract/Free Full Text]
• Kjerulff KH, Langenberg P., Seidman JD, Stolley PD, Guzinski GM (1996). Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis. J Reprod Med 41: 483—490.[Web of Science][Medline] [Order article via Infotrieve]
• Marshall LM, Spiegelman D., Barbieri RL, Goldman MB, Manson JE, Colditz GA, Willett WC, Hunter DJ (1997). Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol 90: 967—973.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Marshall LM, Spiegelman D., Goldman MB, Manson JE, Colditz GA, Barbieri RL, Stampfer MJ, Hunter DJ (1998). A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata. Fertil Steril 70: 432—439.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Marshall LM, Spiegelman D., Manson JE, Goldman MB, Barbieri RL, Stampfer MJ, Willett WC, Hunter DJ (1998). Risk of uterine leiomyomata among premenopausal women in relation to body size and cigarette smoking. Epidemiology 9: 511—517.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Murkies AL, Wilcox G., Davis SR (1998). Clinical review 92: Phytoestrogens. J Clin Endocrinol Metab 83: 297—303.[Abstract/Free Full Text]
• Murphy LJ, Ghahary A. (1990). Uterine insulin-like growth factor-1: Regulation of expression and its role in estrogen-induced uterine proliferation. Endocr Rev 11: 443—453.[Abstract/Free Full Text]
• Murphy LJ, Murphy LC, Friesen HG (1987). Estrogen induces insulin-like growth factor-I expression in the rat uterus. Mol Endocrinol 1: 445—450.[Abstract/Free Full Text]
• Parazzini F., Negri E., La Vecchia C., Chatenoud L., Ricci E., Guarnerio P. (1996). Reproductive factors and risk of uterine fi broids. Epidemiology 7: 440—442.[Web of Science][Medline] [Order article via Infotrieve]
• Parazzini F., Negri E., La Vecchia C., Fedele L., Rabaiotti M., Luchini L. (1992). Oral contraceptive use and risk of uterine fibroids. Obstet Gynecol 79: 430 — 433.[Web of Science][Medline] [Order article via Infotrieve]
• Parazzini F., Negri E., La Vecchia C., Rabaiotti M., Luchini L., Villa A., Fedele L. (1996). Uterine myomas and smoking. Results from an Italian study. J Reprod Med 41: 316—320.[Web of Science][Medline] [Order article via Infotrieve]
• Rao GN (1996). Influence of diet on tumors of hormonal tissues. In: Cellular and Molecular Mechanisms of Hormonal Carcinogenesis, Huff J, Boyd J, Barrett JC (eds). Wiley-Liss, New York, pp 41—56.
• Richards RG, DiAugustine RP, Petrusz P., Clark GC, Sebastian J. (1996). Estradiol stimulates tyrosine phosphorylation of the insulin-like growth factor-1 receptor and insulin receptor substrate-1 in the uterus. Proc Natl Acad Sci USA 93: 12002—12007.[Abstract/Free Full Text]
• Rivlin ME, Patel RB, Hess LW, Hess DB, Meeks GR (1994). Leuprolide acetate depot for the treatment of uterine leiomyomas. Changes in bone density, uterine volume and uterine vascular resistive index. J Reprod Med 39: 663—666.[Web of Science][Medline] [Order article via Infotrieve]
• Walker C., Burroughs K., Davis B., Sowell K., Everitt J., Fuchs-Young R. (2000). Preclinical evidence for therapeutic effi cacy of selective estrogen receptor modulators for uterine leiomyoma. J Soc Gynecol Invest 7: 249—256.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Washburn S., Burke GL, Morgan T., Anthony M. (1999). Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause 6: 7—13.[Medline] [Order article via Infotrieve]
• Werner H., Le Roth D. (1997). The insulin-like growth factor-I receptor signaling pathways are important for tumorigenesis and inhibition of apoptosis. Crit Rev Oncog 8: 71—92.[Web of Science][Medline] [Order article via Infotrieve]
• Wolff MS, Toniolo PG, Lee EW, Rivera M., Dubin N. (1993). Blood levels of organochlorine residues and risk of breast cancer. J Natl Cancer Inst 85: 648—652.[Abstract/Free Full Text]

Toxicologic Pathology, Vol. 29, No. 1, 100-104 (2001)
DOI: 10.1080/019262301301418900


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Houston, K. D. Articles by Walker, C. L. Search for Related Content PubMed PubMed Citation Articles by Houston, K. D. Articles by Walker, C. L. Social Bookmarking                         What's this?